Medtronic (MDT) Gains from Investment Securities (2016 - 2026)
Medtronic (MDT) has disclosed Gains from Investment Securities for 13 consecutive years, with $1.8 billion as the latest value for Q1 2026.
- Quarterly Gains from Investment Securities rose 230.84% to $1.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.9 billion through Jan 2026, up 263.48% year-over-year, with the annual reading at $249.0 million for FY2025, 4.6% down from the prior year.
- Gains from Investment Securities hit $1.8 billion in Q1 2026 for Medtronic, up from -$292.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.8 billion in Q1 2026 to a low of -$1.4 billion in Q1 2024.
- Historically, Gains from Investment Securities has averaged $269.0 million across 5 years, with a median of $154.0 million in 2022.
- Biggest five-year swings in Gains from Investment Securities: plummeted 3944.12% in 2024 and later surged 1288.89% in 2025.
- Year by year, Gains from Investment Securities stood at -$408.0 million in 2022, then surged by 343.38% to $993.0 million in 2023, then soared by 33.53% to $1.3 billion in 2024, then crashed by 122.02% to -$292.0 million in 2025, then surged by 704.45% to $1.8 billion in 2026.
- Business Quant data shows Gains from Investment Securities for MDT at $1.8 billion in Q1 2026, -$292.0 million in Q4 2025, and $125.0 million in Q3 2025.